Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000831482) titled 'Validation of a patient-reported symptom tool to identify pancreatic exocrine insufficiency in pancreatic cancer' on Aug. 4.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Type of endpoint: Efficacy
Primary Sponsor: University of Otago
Condition:
Pancreatic exocrine insufficiency
Pancreatic exocrine insufficiency
Cancer - Pancreatic
Intervention:
The study research assistant will administer the new Exocrine Pancreatic Insufficiency/Pancreatic Exocrine Insufficiency- Symptom Score (EPI/PEI-SS) tool online to collect information about whether people recruited ...